Case Studies

Buyon J, et al. LSM 2016 – Reduction in EC4d and anti-C1q antibodies associate with clinical improvement in SLE.

Putterman C, et al. LSM. 2014. Cell_bound complement activation products in systemic lupus erythematosus.

Wallace D, et al. LSM. 2016. Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products.

View Publication

Dr. Shawn Macalester

57 -Year Old SLE Patient With Evolving Symptomatology.

View Publication

Dr. Chris Collins

42 Year Old Female African American. Chief complaint: worsening joint pain.

View Publication

Dr. James Mossell

59 Year Old Caucasian Female. Chief complaint: arthralgias, dry eyes and hair loss.

View Publication

Dr. Nehad Soloman

18 Year Old Female. Chief Complaint: chronic fatigue and achy joints.

View Publication

Dr. CJ Alappatt

28 year old Female. Chief Complaint: arthralgia, myalgia and fatigue.

View Publication

Merrill J, et al. LSM 2018 – Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE.

View Publication

Ramsey-Goldman R, et al. LSM 2017 • Cell-bound complement activation products in SLE

View Publication

Dr. Priya Reddy

47 Year Old Female. Chief Complaint: overlapping symptoms with ANA positivity.

View Publication